Archive · 22 Jul 2026
Reliance's Tira Launches South Korean Dermo-Cosmetic Brand Dr. Melaxin in India
Reliance Retail's beauty platform, Tira, has launched Dr. Melaxin, a South Korean dermo-cosmetic brand, in India.
Dermo-cosmetics are products that sit between prescription dermatology and regular skincare, focusing on specific skin concerns with clinical backing.
The Indian skincare market is growing rapidly, with a 13% increase in value in 2025, driven by demand for clinically proven products.
Dr. Melaxin's products, like the Peel Shot range, target issues such as pigmentation and skin aging.
Both pharmaceutical companies and beauty retailers are expanding in this market, offering consumers a variety of options.
The launch aims to provide Indian consumers with access to science-backed skincare solutions.
Reliance Retail's Tira launches South Korean dermo-cosmetic brand Dr. Melaxin in India.
Dr. Melaxin's products target pigmentation, enlarged pores, skin aging, and loss of firmness.
The brand's formulations are inspired by vaccine science and dermatologist-tested.
India's skincare market grew 13% in 2025 to ₹32,210 crore, driven by demand for clinically positioned products.
Pharmaceutical companies and beauty retailers are expanding their presence in the dermo-cosmetic market.
- Who
- Reliance Retail's Tira and Dr. Melaxin
- What
- Launch of South Korean dermo-cosmetic brand in India
- When
- Not specified
- Where
- India
- Why
- To address growing demand for clinically positioned skincare products
Pharmaceutical Companies
Beauty Retailers
Market Expansion
Pharmaceutical Companies
Pharmaceutical companies are expanding their presence in the dermo-cosmetic market, offering clinically positioned products.
Beauty Retailers
Beauty retailers like Tira are partnering with international brands to bring science-backed skincare products to consumers.
- Brand
- Dr. Melaxin
- Parent Company
- Reliance Retail
- Platform
- Tira
- Market Size
- ₹32,210 crore
- Growth Rate
- 13%
- Key Products
- Peel Shot range
- CEO
- Yu Kyoung Hwa